ALPS Medical Breakthroughs ETF
SBIO
48 hedge funds and large institutions have $45M invested in ALPS Medical Breakthroughs ETF in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 13 closing their positions.
2.29% less ownership
Funds ownership: 29.35% → 27.06% (-2.3%)
13% less funds holding
Funds holding: 55 → 48 (-7)
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
47% less capital invested
Capital invested by funds: $84.4M → $45M (-$39.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFG
Bouchey Financial Group
Troy,
New York
|
+$3.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.41M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.69M |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$1.5M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$826K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$8.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.21M |
| 3 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$4.02M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$3.59M |
| 5 |
Morgan Stanley
New York
|
-$2.97M |
SBIO Hedge Fund Activity: Q4 2018 in Review
48 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2018, worth a combined $45M — down 47% from $84.4M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SBIO and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 15 added.
The largest buyer was Bouchey Financial Group, adding an estimated $3.7M. The largest seller was Bank of America, cutting an estimated $8.39M.
- 48 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2018, down from 55 in Q3 2018.
- Funds reported $45M of ALPS Medical Breakthroughs ETF stock for Q4 2018, down 47% quarter-over-quarter.
- 8 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2018 and 13 closed out, a net change of -5 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2018 was Bouchey Financial Group, an estimated $3.7M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2018 was Bank of America, an estimated $8.39M sold.
Based on aggregated 13F filings for Q4 2018.